Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

467 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Disabled-2, a versatile tissue matrix multifunctional scaffold protein with multifaceted signaling: Unveiling its potential in the cancer battle.
Shah NN, Dave BP, Shah KC, Shah DD, Maheshwari KG, Chorawala MR, Parekh PS, Jani M. Shah NN, et al. Among authors: shah kc, shah dd. Naunyn Schmiedebergs Arch Pharmacol. 2024 Aug;397(8):5533-5557. doi: 10.1007/s00210-024-03037-3. Epub 2024 Mar 19. Naunyn Schmiedebergs Arch Pharmacol. 2024. PMID: 38502243 Review.
Access to CARe: A Narrative of Real-World Medical Decision-Making to Access Chimeric Antigen Receptor (CAR) T-Cell Therapy in Children, Adolescents, and Young Adults.
Steineck A, Chao K, Hall AG, Jacoby E, Leahy AB, Ligon JA, Luciani K, Schultz LM, Summers CN, Ward L, Winestone LE, Shah NN. Steineck A, et al. Among authors: shah nn. Pediatr Blood Cancer. 2025 Jan 23:e31516. doi: 10.1002/pbc.31516. Online ahead of print. Pediatr Blood Cancer. 2025. PMID: 39844726
Characterizing features affecting local ancestry inference performance in admixed populations.
Honorato-Mauer J, Shah NN, Maihofer AX, Zai CC, Belangero S, Nievergelt CM; Psychiatric Genomics Consortium for PTSD Ancestry Working Group; Santoro M, Atkinson EG. Honorato-Mauer J, et al. Among authors: shah nn. Am J Hum Genet. 2024 Dec 26:S0002-9297(24)00447-6. doi: 10.1016/j.ajhg.2024.12.005. Online ahead of print. Am J Hum Genet. 2024. PMID: 39753130
Evolving strategies for addressing CAR T-cell toxicities.
Rankin AW, Duncan BB, Allen C, Silbert SK, Shah NN. Rankin AW, et al. Among authors: shah nn. Cancer Metastasis Rev. 2024 Dec 15;44(1):17. doi: 10.1007/s10555-024-10227-1. Cancer Metastasis Rev. 2024. PMID: 39674824 Free PMC article. Review.
Efficient manufacturing of CAR-T cells from whole blood: a scalable approach to reduce costs and enhance accessibility in cancer therapy.
Traynor R, Vignola I, Sarkar S, Prochazkova M, Cai Y, Shi R, Underwood S, Ramanujam S, Yates B, Silbert S, Jin P, Dreyzin A, Shah NN, Somerville RP, Stroncek DF, Song HW, Highfill SL. Traynor R, et al. Among authors: shah nn. Cytotherapy. 2024 Dec 8:S1465-3249(24)00939-3. doi: 10.1016/j.jcyt.2024.11.013. Online ahead of print. Cytotherapy. 2024. PMID: 39652017 Free article.
Development of ALL-Hematotox (ALL-HT): Predicting post CAR T-cell hematotoxicity in B-cell acute lymphoblastic leukemia.
Nair MS, Silbert SK, Rejeski K, Wilson KA, Lamble AJ, Valtis YK, Yates B, Morales Arana A, Shouval R, Curran KJ, Gardner RA, Shalabi H, Annesley C, Park JH, Subklewe M, Shah NN. Nair MS, et al. Among authors: shah nn. Blood. 2024 Nov 19:blood.2024025910. doi: 10.1182/blood.2024025910. Online ahead of print. Blood. 2024. PMID: 39561284
CRLF2-rearranged B-cell ALL with extramedullary lineage switch to AML following CD19-targeted therapy.
Silbert SK, Scanlon S, Wang HW, Yuan CM, Doverte A, Wellek J, Patel N, Braylan R, Ahlman M, Turkbey EB, Bohling SD, Chisholm KM, Oztek MA, LaLoggia M, Verma A, Shalabi H, Kovach AE, Wood BL, Lamble A, Kirsch I, Leger K, Shah NN. Silbert SK, et al. Among authors: shah nn. J Immunother Cancer. 2024 Oct 26;12(10):e009499. doi: 10.1136/jitc-2024-009499. J Immunother Cancer. 2024. PMID: 39461880 Free PMC article.
467 results